Publications by authors named "Robert L Martuza"

81Publications

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.

Acta Neuropathol Commun 2020 12 11;8(1):221. Epub 2020 Dec 11.

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, MA, 02114, USA.

View Article and Find Full Text PDF
December 2020

Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.

Clin Cancer Res 2021 Feb 30;27(3):889-902. Epub 2020 Nov 30.

Department of Neurosurgery, Brain Tumor Research Center, Massachusetts General Hospital, Boston, Massachusetts.

View Article and Find Full Text PDF
February 2021

Adjuvant Radiation Therapy Versus Surveillance After Surgical Resection of Atypical Meningiomas.

Int J Radiat Oncol Biol Phys 2021 Jan 8;109(1):252-266. Epub 2020 Aug 8.

Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

View Article and Find Full Text PDF
January 2021

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma.

J Immunother Cancer 2020 05;8(1)

Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article and Find Full Text PDF
May 2020

Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma.

Nat Commun 2019 07 2;10(1):2910. Epub 2019 Jul 2.

Molecular Neurosurgery Laboratory and the Brain Tumor Research Center and Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, 02114, MA, USA.

View Article and Find Full Text PDF
July 2019

Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells.

Mol Ther Oncolytics 2019 Jun 29;13:58-66. Epub 2019 Mar 29.

Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

View Article and Find Full Text PDF
June 2019

Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma.

Immunotherapy 2018 07;10(9):779-786

Department of Neurosurgery, Molecular Neurosurgery Laboratory & Brain Tumor Research Center, Massachusetts General Hospital & Harvard Medical School, Boston, MA 02114, USA.

View Article and Find Full Text PDF
July 2018

Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.

Clin Cancer Res 2018 07 29;24(14):3409-3422. Epub 2018 Mar 29.

Molecular Neurosurgery Laboratory and the Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts.

View Article and Find Full Text PDF
July 2018

Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade.

Oncoscience 2017 Jul 20;4(7-8):67-69. Epub 2017 Sep 20.

Molecular Neurosurgery Laboratory and the Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
July 2017

Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade.

Cancer Cell 2017 08;32(2):253-267.e5

Molecular Neurosurgery Laboratory and the Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA; Department of Neurosurgery, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article and Find Full Text PDF
August 2017

Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.

J Natl Cancer Inst 2017 03;109(3):1-13

Molecular Neurosurgery Laboratory, Brain Tumor Research Center, Massachusetts General Hospital, Boston, MA, USA.

View Article and Find Full Text PDF
March 2017